BiotechTube
Eureka Biotechnology

Eureka Biotechnology

San Diego, United States· Est.
eurekabiotechnology.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Eureka Biotech, founded in 2015 and headquartered in Philadelphia, Pennsylvania, is a private, pre-revenue biotech firm specializing in induced pluripotent stem cell (iPSC) and organoid platforms. Its core activities include developing disease-specific iPSCs, brain and heart organoids for drug screening, and artificial skin models, with a secondary initiative in cultured meat production. The company operates as a subsidiary of the Eureka International Group and is strategically positioned near major academic institutions to facilitate research and collaboration.

Oncology

Technology Platform

Induced Pluripotent Stem Cell (iPSC) differentiation into complex organoids (brain, heart, artificial skin) and application for cultured meat production.

Opportunities

The growing demand for human-relevant, predictive models in drug discovery creates a significant market for high-quality organoids.
The cultivated meat industry presents a large, emerging market where stem cell technology could be disruptive if scaling challenges are overcome.

Risk Factors

The company faces technical risks in consistently producing complex organoids and scaling cultured meat production.
Its dual focus on pharma tools and food tech may dilute resources, and it operates in highly competitive landscapes in both sectors.

Competitive Landscape

In organoids, Eureka competes with established players like STEMCELL Technologies, Cellesce, and numerous academic spin-offs. In cultured meat, it faces dedicated food tech companies (e.g., Upside Foods, Good Meat) with substantial funding. Its niche may be leveraging its stem cell platform across both fields.

More companies in Biologics / Biosimilars →More companies in United States →